Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 19, 2024

Trends in the Use of Glucose-Lowering Therapies Among Patients at High Cardiovascular Risk

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Three decades of glucose-lowering therapy in patients at high cardiovascular risk - A real-world analysis
Diabetes Obes Metab 2024 Nov 27;[EPub Ahead of Print], M Neyer, JB Vogel, P Elsner, H Kuehrer, CH Saely, A Muendlein, A Vonbank, A Mader, A Festa, H Drexel, A Leiherer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading